OVX033, a nucleocapsid-based vaccine candidate, provides broad-spectrum protection against SARS-CoV-2 variants in a hamster challenge model

Overview of attention for article published in Frontiers in immunology, June 2023

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (97th percentile)
High Attention Score compared to outputs of the same age and source (98th percentile)

So far, Altmetric has seen 8 posts from 1 blogs.

This month, most of the news is in mucosal vaccine development again. These vaccines aim to block Covid infection. An aerosol…

Mucosal vaccines go directly into the mucosal tissue where infection begins – for example, intranasally or via tablets. If they…

The race for next generation vaccines is steadily heating up now. And this month, we’ve passed a major milestone: The first…

A next generation vaccine has been authorized by a major drug regulator for the first time. It’s based on a next generation mRNA…

This page shows the most recent blog posts that mention this research output.

Click here to find out how to access more activity, including 4 additional blog posts.